Medicine and Dentistry
Meta-Analysis
100%
Systematic Review
63%
Randomized Controlled Trial
58%
Cohort Analysis
53%
Apoplexy
47%
Disease
41%
Odds Ratio
40%
Malignant Neoplasm
34%
Injury
31%
Breast Cancer
31%
Prevalence
30%
Hazard Ratio
29%
Infection
23%
Diabetes
22%
Chronic Kidney Disease
19%
Traumatic Brain Injury
19%
Logistic Regression Analysis
18%
Brain Ischemia
17%
Neoplasm
16%
Urinary System
16%
Body Mass Index
15%
COVID-19
15%
Programmed Cell Death
15%
Diabetes Mellitus
15%
Cancer Cell
15%
Medicine
15%
Cross Sectional Study
14%
Symptom
13%
Health Care Cost
13%
Disability
13%
Drug Therapy
12%
Cardiovascular Disease
12%
Proportional Hazards Model
12%
Health Care
12%
Lung Cancer
11%
Particular Matter 2.5
11%
Rehabilitation Engineering
11%
Hepatocellular Carcinoma
11%
Quality of Life
11%
Maturity Onset Diabetes of the Young
11%
Case-Control Study
11%
Retrospective Cohort Study
11%
Childbirth
10%
Biological Marker
10%
Public Health
10%
Metastatic Carcinoma
10%
Mortality Rate
10%
In Vitro
10%
Multidrug Resistant Tuberculosis
9%
Ischemic Heart Disease
9%
Global Disease Burden
9%
Middle Age
9%
Methylation
9%
Chronic Obstructive Pulmonary Disease
9%
Cancer Risk
9%
Adverse Event
9%
Computer Assisted Tomography
9%
Health Survey
9%
Blood Pressure
9%
Diagnosis
8%
Human Immunodeficiency Virus
8%
Outpatient
8%
Cohort Effect
8%
Survival Rate
8%
Atmospheric Aerosol
8%
Adolescent
8%
Cardiovascular System
8%
Emergency Department
7%
Cesarean Section
7%
Network Meta-Analysis
7%
Surgeon
7%
Cytotoxicity
7%
Asthma
7%
Retrospective Study
7%
Kidney Function
7%
Cigarette Smoking
7%
Dietary Pattern
7%
Surgery
7%
Supplementation
7%
Long-Term Care
6%
Metabolic Syndrome
6%
Random Effects Model
6%
Lung Tuberculosis
6%
Glioblastoma
6%
Recurrent Disease
6%
Kawasaki Disease
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Anemia
6%
Transitional Cell Carcinoma
6%
Signal Transduction
6%
Closed Head Injury
6%
Population
6%
Magnetic Resonance Imaging
6%
Smoking
6%
Overall Survival
6%
Colorectal Cancer
5%
Parkinson's Disease
5%
Cancer
5%
Premature Labor
5%
Prospective Cohort Study
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
69%
Malignant Neoplasm
60%
Disease
57%
Randomized Controlled Trial
44%
Mouse
33%
Inflammation
30%
Prevalence
29%
Breast Cancer
28%
Injury
28%
Neoplasm
26%
Chronic Kidney Failure
22%
Infection
21%
Reactive Oxygen Metabolite
19%
Liver Cell Carcinoma
19%
Diabetes Mellitus
18%
Cytotoxicity
17%
Nitric Oxide
17%
Cardiovascular Disease
17%
Biological Marker
16%
Brain Ischemia
15%
Adverse Event
15%
Lipopolysaccharide
15%
Lung Cancer
15%
Transitional Cell Carcinoma
14%
Traumatic Brain Injury
14%
Cyclooxygenase 2
14%
Comorbidity
13%
Case-Control Study
13%
Antioxidant
13%
Tumor Necrosis Factor
13%
Chronic Obstructive Lung Disease
13%
Protein P53
12%
Caspase 3
12%
Glioblastoma
11%
Chemotherapy
11%
Heme Oxygenase 1
11%
Inducible Nitric Oxide Synthase
10%
Colon Cancer
10%
Colorectal Cancer
10%
Mortality Rate
10%
Hemodialysis
10%
Cigarette Smoking
10%
Symptom
10%
Survival Rate
10%
Vaccination Policy
10%
Sleep Disordered Breathing
10%
Ischemic Heart Disease
10%
Non Insulin Dependent Diabetes Mellitus
9%
Well Water
9%
Phosphotransferase
9%
Rheumatoid Arthritis
9%
Anti-Inflammatory Drug
9%
Long Term Exposure
9%
Bladder Cancer
9%
Nicotinic Receptor
8%
Epidermal Growth Factor Receptor
8%
Mitogen Activated Protein Kinase
8%
Western Blot
8%
Hepatitis C Virus
8%
Overall Survival
8%
Interleukin 6
7%
Glutathione
7%
Global Disease Burden
7%
Carcinogenesis
7%
Parkinson's Disease
7%
Asthma
7%
HIV
7%
All Cause Mortality
7%
Clinical Trial
7%
Placebo
7%
Cytokine
7%
Low Birth Weight
7%
Head Injury
7%
Prostaglandin E2
7%
Polycyclic Aromatic Hydrocarbon
7%
Combination Therapy
7%
Metabolic Syndrome X
7%
Antivirus Agent
7%
Dose-Response Relationship
6%
Hyperlipidemia
6%
Recurrent Disease
6%
Observational Study
6%
Hepatitis C
6%
Liver Cancer
6%
Ethanol
6%
Multi-Drug-Resistant Tuberculosis
6%
12-O-Tetradecanoylphorbol-13-Acetate
6%
Antiinflammatory Activity
6%
End Stage Renal Disease
6%
Prostate Cancer
6%
C Reactive Protein
6%
Quercetin
6%
Proton Pump Inhibitor
6%
Cell Viability
5%
Rifampicin
5%
Mouse Model
5%
Metastasis
5%
Carotid Atherosclerosis
5%
Triacylglycerol
5%
Antiinfective Agent
5%
Nursing and Health Professions
Meta Analysis
71%
Confidence Interval
70%
Systematic Review
42%
Odds Ratio
41%
Cohort Analysis
31%
Injury
30%
Disease
30%
Quality of Life
26%
Traumatic Brain Injury
25%
Prevalence
25%
World Health Organization
22%
Cross-Sectional Study
21%
National Health Insurance
21%
Logistic Regression Analysis
20%
Rehabilitation Engineering
19%
Disability
17%
Hazard Ratio
16%
Symptom
15%
Drug Therapy
15%
Breast Cancer
15%
Health Service
14%
Health Care Personnel
12%
Hospital
12%
Practice Guideline
12%
Malignant Neoplasm
11%
Outpatient
10%
Human Immunodeficiency Virus
10%
Comorbidity
10%
Mortality Rate
9%
Long Term Care
9%
Health Survey
9%
Health Literacy
9%
Case-Control Study
9%
Head Injury
9%
Medline
9%
Emergency Ward
9%
Pilot Study
9%
Cochrane Library
8%
Adolescent
8%
Diabetes Mellitus
8%
Health Status
8%
Psychometry
8%
Cigarette Filter
8%
Spinal Cord Injury
8%
Chronic Kidney Failure
8%
Infection
7%
Supplementation
7%
Cardiovascular Disease
7%
Body Mass
7%
Self Care
6%
Independent Practice Association
6%
Mental Health
6%
Gender Difference
6%
Receiver Operating Characteristic
6%
Teaching Hospital
6%
Metabolic Syndrome X
6%
Multivariate Logistic Regression Analysis
6%
Adverse Event
6%
Depression
6%
Brain Ischemia
6%
Injury Severity
6%
Correlation Coefficient
6%
Severe Acute Respiratory Syndrome
6%
Hyperlipidemia
6%
Body Composition
6%
International Classification of Functioning, Disability and Health
5%
Shared Decision-Making
5%
Internal Consistency
5%
Embase
5%
Blood Pressure
5%
Chronic Disease
5%
Placebo
5%
Test Retest Reliability
5%
Non Insulin Dependent Diabetes Mellitus
5%